Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Cancer Care Northwest - Spokane South
mi
from
Spokane, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Cancer Care Northwest - Spokane South
mi
from
Spokane, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Evergreen Hematology and Oncology, PS
mi
from
Spokane, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Evergreen Hematology and Oncology, PS
mi
from
Spokane, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Wenatchee Valley Hospital and Clinics
mi
from
Wenatchee, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Wenatchee Valley Hospital and Clinics
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Oncology
mi
from
Casper, WY
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Oncology
mi
from
Casper, WY
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Welch Cancer Center
mi
from
Sheridan, WY
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Welch Cancer Center
mi
from
Sheridan, WY
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Fort Smith
mi
from
Fort Smith, AR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Fort Smith
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
mi
from
Topeka, KA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
mi
from
Topeka, KA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Frontier Cancer Center
mi
from
Billings, MT
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Frontier Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Shawnee Mission Medical Center-KCCC
mi
from
Shawnee Mission, KA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Shawnee Mission Medical Center-KCCC
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Hospital,
mi
from
Mobile, AL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Hospital,
mi
from
Mobile, AL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Highlands Oncology Group-Rogers
mi
from
Rogers, AR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Highlands Oncology Group-Rogers
mi
from
Rogers, AR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
UF Cancer Center at Orlando Health
mi
from
Orlando, FL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
UF Cancer Center at Orlando Health
mi
from
Orlando, FL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
mi
from
Savannah, GA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
mi
from
Savannah, GA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Southwest Medical Center
mi
from
Liberal, KA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Southwest Medical Center
mi
from
Liberal, KA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Benefis Healthcare- Sletten Cancer Institute
mi
from
Great Falls, MT
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Benefis Healthcare- Sletten Cancer Institute
mi
from
Great Falls, MT
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Wayne Memorial Hospital
mi
from
Goldsboro, NC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Wayne Memorial Hospital
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Milwaukie Hospital
mi
from
Milwaukie, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Milwaukie Hospital
mi
from
Milwaukie, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Providence Saint Vincent Medical Center
mi
from
Portland, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Providence Saint Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Salem Hospital
mi
from
Salem, OR
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Salem Hospital
mi
from
Salem, OR
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Greenville, SC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Hospital and Medical Center
mi
from
Kingsport, TN
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Hospital and Medical Center
mi
from
Kingsport, TN
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Thompson Cancer Survival Center
mi
from
Knoxville, TN
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Thompson Cancer Survival Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Southwest VA Regional Cancer Center
mi
from
Norton, VA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Southwest VA Regional Cancer Center
mi
from
Norton, VA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
PeaceHealth Southwest Medical Center
mi
from
Vancouver, WA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
PeaceHealth Southwest Medical Center
mi
from
Vancouver, WA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Memorial Health University Medical Center
mi
from
Savannah, GA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
AMG Oncology - Naperville
mi
from
Naperville, IL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
AMG Oncology - Naperville
mi
from
Naperville, IL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
FirstHealth of the Carolinas-Moore Regional Hospital
mi
from
Pinehurst, NC
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
FirstHealth of the Carolinas-Moore Regional Hospital
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Sovah Health Martinsville
mi
from
Martinsville, VA
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Sovah Health Martinsville
mi
from
Martinsville, VA
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Miami Valley Hospital North
mi
from
Dayton, OH
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Miami Valley Hospital North
mi
from
Dayton, OH
Click here to add this to my saved trials
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated:  12/31/1969
Ascension Saint Mary's Hospital
mi
from
Saginaw, MI
Dinaciclib in Treating Patients With Stage IV Melanoma
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Status: Enrolling
Updated: 12/31/1969
Ascension Saint Mary's Hospital
mi
from
Saginaw, MI
Click here to add this to my saved trials
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Rockefeller University
mi
from
New York, NY
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Center for Dermatology Clinical Research
mi
from
Fremont, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Center for Dermatology Clinical Research
mi
from
Fremont, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Dermatology Specialists, Inc
mi
from
Murrieta, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Dermatology Specialists, Inc
mi
from
Murrieta, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Dermatology Specialists, Inc.
mi
from
Oceanside, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Dermatology Specialists, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Contour Dermatology & Cosmetic Surgery Center
mi
from
Rancho Mirage, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Contour Dermatology & Cosmetic Surgery Center
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Skin Surgery Medical Group, Inc.
mi
from
San Diego, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Skin Surgery Medical Group, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Therapeutics Clinical Research
mi
from
San Diego, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
University Clinical Trials, Inc.
mi
from
San Diego, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
University Clinical Trials, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Colorado Medical Research Center
mi
from
Denver, CO
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Colorado Medical Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
AboutSkin Dermatology and DermSurgery
mi
from
Greenwood Village, CO
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
AboutSkin Dermatology and DermSurgery
mi
from
Greenwood Village, CO
Click here to add this to my saved trials